Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology.
about
Electrophysiological study of V535M hERG mutation of LQT2.Sick sinus syndrome associated with hypopituitarism: a case report and literature review.Cardiac arrhythmias in women.Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk.Acute toluene intoxication--clinical presentation, management and prognosis: a prospective observational study.Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndromeFeminizing adrenal carcinoma presenting with heart failure and ventricular tachycardia.Increased late sodium current contributes to long QT-related arrhythmia susceptibility in female mice.Contrasting Nav1.8 Activity in Scn10a-/- Ventricular Myocytes and the Intact Heart.Male hormonal contraception: potential risks and benefits.Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography.Roles of Testosterone Replacement in Cardiac Ischemia-Reperfusion Injury.Impact of sex and ethnicity on arrhythmic risk.Gender differences in the effects of cardiovascular drugs.Genetic biomarkers for the risk of seizures in long QT syndrome.Inter-individual variability and modeling of electrical activity: a possible new approach to explore cardiac safety?Sex as a Biological Variable in Emergency Medicine Research and Clinical Practice: A Brief Narrative Review.Effects of testosterone on the Q-T interval in older men and older women with chronic heart failure.Risk of cardiac events in Long QT syndrome patients when taking antiseizure medications.Ventricular remodelling is a prerequisite for the induction of dofetilide-induced torsade de pointes arrhythmias in the anaesthetized, complete atrio-ventricular-block dog.A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.QT interval and the risk of myocardial infarction and all-cause death: a cohort study.[Gender aspects in anesthesia : modified approach in research and treatment?].Androgen Deprivation Therapy Is Associated With Prolongation of QTc Interval in Men With Prostate Cancer.
P2860
Q33160777-DEB069E5-F1FC-4BDF-9D01-35CDE8D69A9DQ33164887-79D6A893-AE33-461C-A71B-4B502A278466Q34736602-4562A322-2744-4F93-8AF1-C8CE8EAB056BQ35210010-BD6E9AC5-DE35-4253-A22D-1E4203C45123Q35748089-9277370D-E3D5-448F-ABC6-A6373A39953CQ36054655-077BF4B2-5FE5-43F9-8902-EC95D94CEF88Q36168764-67509C6D-4E10-4EF9-85EC-CD19B50057E3Q36787316-ECD5DD4F-C910-40D0-B5B8-02A06E46C76DQ37556182-3DB1584B-7999-45FB-BB56-87DBD28F4D91Q37872647-7290BC73-04BB-483F-894A-53C25D613759Q38081112-B8E7EBA8-030B-4614-B88F-2A5E15C85377Q38503935-EB92E4F9-0979-44CA-9C89-3845428B3BCAQ38508942-90EB888F-FCAA-4E34-82C6-745246B78857Q39193538-6FCD6E62-FAC1-4077-BA5B-EEE09BA9DCF8Q40537132-25B11F51-CA56-4355-916C-4A602BEBC621Q42361494-A7D5489D-0A92-492B-AE19-15AB5C076125Q42783608-FDE40F94-6B3D-458F-B067-9788DBF63D08Q44080022-43E06FEB-F58F-4287-AB0C-C037F27A4169Q47584744-AC9600CD-FB99-4A1C-B831-8639DD3B94CDQ48228257-01A73F0E-2EC1-4A52-B1F9-77427A634D14Q51301390-26F41337-81D9-44D2-B067-2511E474029FQ51346001-56498065-BC1A-4F2F-B1B9-E69F318E181DQ53098680-FFCF83C6-2E11-4ABE-AB6E-4CCD82A4BD3CQ55278779-329EAB5E-55A0-44B4-9E92-1B1C6580E6A1
P2860
Gender disparity in cardiac electrophysiology: implications for cardiac safety pharmacology.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Gender disparity in cardiac el ...... r cardiac safety pharmacology.
@en
Gender disparity in cardiac el ...... r cardiac safety pharmacology.
@nl
type
label
Gender disparity in cardiac el ...... r cardiac safety pharmacology.
@en
Gender disparity in cardiac el ...... r cardiac safety pharmacology.
@nl
prefLabel
Gender disparity in cardiac el ...... r cardiac safety pharmacology.
@en
Gender disparity in cardiac el ...... r cardiac safety pharmacology.
@nl
P2093
P1476
Gender disparity in cardiac el ...... or cardiac safety pharmacology
@en
P2093
S Demolombe
T A B van Veen
P356
10.1016/J.PHARMTHERA.2010.04.002
P577
2010-05-10T00:00:00Z